Sunitinib Malate Capsule
Product Images NDC 72205-119

This description provides details about a medication containing 12.5 mg of sunitinib, equivalent to 16.7 mg sunitinib malate. The normal dosage and storage instructions are included, with guidance on temperature control and dispensing in airtight containers. The manufacturer is identified as MSN Laboratories Private Limited in Telangana, India, and Novadoz Pharmaceuticals LLC is listed as the distributor. Pharmacies are instructed to dispense the medication guide to each patient.*

This text provides important information about a medication called Sunitinib Malate, which comes in capsules containing 25 mg of the active ingredient. The usual dosage is not specified in this excerpt, so it may need to be checked in the accompanying instructions. The storage guidelines suggest keeping the capsules between 20°C to 25°C (68°F to 77°F), with excursions permitted in the range of 16°C to 30°C (59°F to 86°F). The medication is to be dispensed in light-resistant containers and kept out of the reach of children. The manufacturer is identified as MSN Laboratories Private Limited in Telangana, India, while the distributor is Novadoz Pharmaceuticals LLC in Piscataway, NJ. The pharmacist is instructed to dispense the accompanying Medication Guide to each patient.*

This text appears to be a medication label for Sunitinib Malate capsules. Each capsule contains 50 1 mg sunitinib malate and is equivalent to 7 Smgsunitnb € 070397-00. The usual dosage instructions are mentioned on the accompanying information. It is advised to store the capsules at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F). The medication should be dispensed in tight containers and kept out of reach of children. The manufacturing company is MSN Laboratories Private Limited in Telangana, INDIA. The medication guide should be dispensed to each patient by the pharmacist. The product is distributed by Novadoz Pharmaceuticals LLC in Piscataway, NJ, USA.*

This text provides information about a medication in capsule form containing 50 mg of sunftnio and its equivalent, 66.8 mg of suritink malate. It includes details on the usual dosage, storage conditions, manufacturer, distributor, and contact information for Novadoz Pharmaceuticals LLC. The medication is intended for prescription use only and should be stored at 20°C to 25°C. The text also emphasizes keeping the capsules out of reach of children.*

This text presents results from a clinical trial comparing the effectiveness of Sunitinib Malate versus Placebo in tumor progression. Sunitinib Malate showed a median time to tumor progression of 27.3 weeks compared to 6.4 weeks for Placebo. The Hazard Ratio was calculated as 0.33 with a 95% confidence interval of 0.23 to 0.47 and a significant p-value of less than 0.0001. The graph provided depicts the time to tumor progression probability over 48 weeks.*